Daptomycin (Teva Parenteral Medicines, Inc.)


Welcome to the PulseAid listing for the Daptomycin drug offered from Teva Parenteral Medicines, Inc.. This Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Parenteral Medicines, Inc.
NON-PROPRIETARY NAME: Daptomycin
SUBSTANCE NAME: DAPTOMYCIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Lipopeptide Antibacterial [EPC],Lipopeptides [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2016-06-15
END MARKETING DATE: 0000-00-00


Daptomycin HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDaptomycin from Teva Parenteral Medicines, Inc.
LABELER NAME: Teva Parenteral Medicines, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/10mL)
START MARKETING DATE: 2016-06-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0703-0125_15a46a51-6c09-47d9-a62a-c7512766e717
PRODUCT NDC: 0703-0125
APPLICATION NUMBER: NDA021572

Other DAPTOMYCIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCDaptomycin
Hospira, Inc.Daptomycin
Merck Sharp & Dohme Corp.Cubicin
Teva Parenteral Medicines, Inc.Daptomycin